ASH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ASH is not a good buy right now for a Beginner long-term investor with $50,000-$100,000 to deploy. The chart is improving technically, but the latest Q2 2026 earnings miss, reduced guidance, and an ongoing securities investigation create too much fundamental and event risk for an immediate long-term buy. If the investor is impatient and wants action now, this is still not the cleanest entry.
ASH is in a short-term constructive trend: MACD histogram is positive and expanding, RSI_6 at 58.9 is neutral-to-bullish, and the moving averages are aligned bullishly with SMA_5 > SMA_20 > SMA_200. Price at 56.15 is trading above the pivot of 54.39 and below resistance at 57.02, with the next resistance at 58.65. This suggests near-term upside is possible, but the stock is not in a strong breakout yet and is still recovering from the post-earnings selloff.
["Seaport Research upgraded Ashland to Buy with a $75 price target, citing potential earnings momentum into fiscal 2027 and activism as a catalyst.", "Technical trend is improving with bullish moving averages and positive MACD expansion.", "Options positioning is bullish with low put-call ratios, suggesting traders are leaning positive.", "Stock is trading near historical lows, which could attract value-oriented buyers.", "Company has an above-market dividend yield noted by analysts."]
["Q2 2026 revenue and non-GAAP EPS missed expectations.", "Management reduced fiscal 2026 guidance.", "Stock fell sharply after earnings, and there is an active securities fraud investigation.", "Analyst targets have generally been cut recently despite some buy ratings, showing cautious sentiment.", "No helpful insider or hedge fund accumulation trend is visible, and there is no congress trading support."]
The latest reported quarter was Q2 2026. Financial performance was weak: revenue and non-GAAP EPS came in below expectations, and guidance for fiscal 2026 was lowered. That points to slowing near-term growth momentum, even though some analysts expect improvement later in fiscal 2027.
Analyst sentiment is mixed but leaning cautious. Recent moves include Seaport upgrading to Buy with a $75 target, while Morgan Stanley cut its target to $58 and kept Equal Weight, Deutsche Bank cut to $60 but kept Buy, JPMorgan cut to $65 and kept Overweight, Mizuho cut to $65 and kept Outperform, Argus cut to $56 and kept Buy, and Evercore ISI raised to $62 and kept In Line. Overall, the Wall Street pros view is that Ashland may have long-term recovery potential, but current fundamentals are still under pressure, so the pro side is constructive but not strongly unanimous.
